Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 5011 AL 5025

The Worldwide Alzheimer's Disease Neuroimaging Initiative: An update

Hendrix JA, Finger B, Weiner MW, Frisoni GB, Iwatsubo T, Rowe CC, Kim SY, Guinjoan SM, Sevlever G, Carrillo MC.

Alzheimers Dement. 2015 Jul;11(7):850-9. doi: 10.1016/j.jalz.2015.05.008.

Phase 3 solanezumab trials: Secondary outcomes in mild Alzheimer's disease patients

Siemers ER, Sundell KL, Carlson C, Case M, Sethuraman G, Liu-Seifert H, Dowsett SA, Pontecorvo MJ, Dean RA, Demattos R.

Alzheimers Dement. 2016 Feb;12(2):110-120. doi: 10.1016/j.jalz.2015.06.1893. Epub 2015 Aug 1.

LDL-lipids from patients with hypercholesterolaemia and Alzheimer's disease are inflammatory to microvascular endothelial cells: mitigation by statin intervention

Dias HK, Brown CL, Polidori MC, Lip GY, Griffiths HR.

Clin Sci (Lond). 2015 Dec;129(12):1195-206. doi: 10.1042/CS20150351. Epub 2015 Sep 23.

Structural Magnetic Resonance Imaging Markers of Alzheimer's Disease and Its Retranslation to Rodent Models

Kincses ZT, Király A, Veréb D, Vécsei L.

J Alzheimers Dis. 2015;47(2):277-90. doi: 10.3233/JAD-143195.

Correlations between Alzheimer's Disease Cerebrospinal Fluid Biomarkers and Cerebral Glucose Metabolism after 12 Months of Phenserine Treatment

Nordberg A, Kadir A, Andreasen N, Almkvist O, Wall A, Långström B, Zetterberg H.

J Alzheimers Dis. 2015;47(3):691-704. doi: 10.3233/JAD-132474.

Impact of Insulin Degrading Enzyme and Neprilysin in Alzheimer's Disease Biology: Characterization of Putative Cognates for Therapeutic Applications

Jha NK, Jha SK, Kumar D, Kejriwal N, Sharma R, Ambasta RK, Kumar P.

J Alzheimers Dis. 2015;48(4):891-917. doi: 10.3233/JAD-150379.

Alzheimer's disease lymphocytes: potential for biomarkers?

Wojda U.

Biomark Med. 2016;10(1):1-4. doi: 10.2217/bmm.15.79. Epub 2015 Dec 7.

Curcumin and curcumin-like molecules: from spice to drugs

Marchiani A, Rozzo C, Fadda A, Delogu G, Ruzza P.

Curr Med Chem. 2014;21(2):204-22. doi: 10.2174/092986732102131206115810.

Inhibition of amyloid-β aggregation in Alzheimer's disease

Wang Q, Yu X, Li L, Zheng J.

Curr Pharm Des. 2014;20(8):1223-43. doi: 10.2174/13816128113199990068.

Disruption of zinc neuromodulation by Aß oligomers: therapeutic implications

Vogler EC, Busciglio J.

Curr Pharm Des. 2014;20(15):2520-4. doi: 10.2174/13816128113199990510.

The effects of soluble Aβ oligomers on neurodegeneration in Alzheimer's disease

Brouillette J.

Curr Pharm Des. 2014;20(15):2506-19. doi: 10.2174/13816128113199990498.

In vivo application of beta amyloid oligomers: a simple tool to evaluate mechanisms of action and new therapeutic approaches

Balducci C, Forloni G.

Curr Pharm Des. 2014;20(15):2491-505. doi: 10.2174/13816128113199990497.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias